Company: LEU
Filing Date: 2025-05-09
Form Type: 424B5
Source: 0001104659-25-046715
Chunk: 30

Company: CENTRUS ENERGY CORP
Filing Date: 2025-05-09
Form: 424B5
Chunk 30
---
-generation nuclear fuels that will power the future of nuclear
energy as it provides reliable carbon-free power around the world.

At present, there are a number
of advanced reactors under development that would use high assay low-enriched uranium (“HALEU”) fuel. Under the HALEU Operation
Contract, Centrus is completing construction a cascade of sixteen AC100M centrifuges in Piketon, Ohio, for the DOE to demonstrate HALEU
production. Centrus expects to begin production of a small quantity of HALEU by the end of 2023 after receiving approval from the U.S.
Nuclear Regulatory Commission (“NRC”). The Company’s goal is to complete the demonstration and scale up production
of HALEU, to meet the needs of new and existing reactors to support energy security as well as national security and other U.S. government
requirements for enriched uranium.

We believe our investments
in our enrichment technology and the HALEU demonstration will position the Company to meet the needs of government and commercial customers
in the future as they deploy advanced reactors and next generation fuels, and also offers potential cost synergies for a return to LEU
production.

Our principal executive office
is located at 6901 Rockledge Drive, Suite 800, Bethesda, Maryland 20817, and our telephone number is (301) 564-3200. Our website
is www.centrusenergy.com. However, the information located on, or accessible from, our website is not, and should not be deemed to be,
part of this prospectus, any accompanying prospectus supplement or any free writing prospectus or incorporated into any other filing
that we submit to the SEC.

<div align='center'>7

Risk Factors</div>

Investing in our securities
involves a high degree of risk. Before making an investment decision, you should carefully consider any risk factors set forth in the
applicable prospectus supplement and the documents incorporated by reference in this prospectus, including the factors discussed under
the heading “Risk Factors” in our most recent Annual Report on Form 10-K and each subsequently filed Quarterly Report
on Form 10-Q and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of
the Securities Exchange. See “Where You Can Find More Information” and “Information We Incorporate By Reference.”
Each of the risks described in these documents could materially and adversely affect our business, financial condition,